10 documents found, page 1 of 1

Sort by Issue Date

Avaliação do Seguimento de 1 Ano dos Pacientes Incluídos no Registro da Prática...

Silva,Pedro Gabriel Melo de Barros e; Berwanger,Otavio; Precoma,Dalton Bertolim; Cavalcante,Margaret Assad; Vilela-Martin,José Fernando

Resumo Fundamento Na prática clínica, há evidências de falhas na prescrição de terapias baseadas em evidências para pacientes de alto risco cardiovascular. Entretanto, no Brasil, ainda são insuficientes os dados sobre a evolução ao longo de 1 ano desses pacientes. Objetivos Descrição no acompanhamento de 12 meses da utilização de terapias baseadas em evidência e da ocorrência de desfechos cardiovasculares maior...

Date: 2021   |   Origin: Oasisbr

Avaliação do Seguimento de um Ano dos Pacientes Incluídos no Registro Brasileir...

Silva,Pedro Gabriel Melo de Barros e; Berwanger,Otavio; Santos,Elizabete Silva dos; Sousa,Antônio Carlos Sobral; Cavalcante,Margaret Assad

Resumo Fundamento Existe carência de informações prospectivas sobre a evolução em um ano após uma síndrome coronária aguda (SCA) em uma grande amostra de pacientes brasileiros. Objetivos Avaliar a prescrição de terapias baseadas em evidência, a ocorrência de desfechos graves e os preditores para estes desfechos em um registro brasileiro multicêntrico de pacientes com SCA. Métodos O ACCEPT é um estudo observacio...

Date: 2020   |   Origin: Oasisbr

Anticoagulation Therapy in Patients with Non-valvular Atrial Fibrillation in a ...

Silva,Pedro Gabriel Melo de Barros e; Sznejder,Henry; Vasconcellos,Rafael; Charles,Georgette M.; Mendonca-Filho,Hugo Tannus F.; Mardekian,Jack

Abstract Background: The safety and effectiveness of warfarin depend on anticoagulation control quality. Observational studies associate poor control with increased morbidity, mortality and healthcare costs. Objectives: To develop a profile of non-valvular atrial fibrillation (NVAF) patients treated with warfarin in a Brazilian private ambulatory and hospital setting, evaluate the quality of anticoagulation con...

Date: 2020   |   Origin: Oasisbr

Prognostic Differences between Men and Women with Acute Coronary Syndrome. Data...

Soeiro,Alexandre de Matos; Silva,Pedro Gabriel Melo de Barros e; Roque,Eduardo Alberto de Castro; Bossa,Aline Siqueira; Biselli,Bruno

Abstract Background: Gender-related differences have been reported in patients with acute coronary syndrome. The description of this comparative finding in a Brazilian registry has not yet been documented. Objective: To compare male vs. female patients regarding the baseline characteristics, coronary findings, treatment and in-hospital and long-term prognosis. Methods: This is a retrospective, multicenter and o...

Date: 2018   |   Origin: Oasisbr

Off-pump versus On-pump Coronary Artery Bypass Grafting in Frail Patients: Stud...

Mejía,Omar Asdrúbal Vilca; Sá,Michel Pompeu Barros Oliveira; Deininger,Maurilio Onofre; Dallan,Luís Roberto Palma; Segalote,Rodrigo Coelho

Abstract Introduction: Advances in modern medicine have led to people living longer and healthier lives. Frailty is an emerging concept in medicine yet to be explored as a risk factor in cardiac surgery. When it comes to CABG surgery, randomized controlled clinical trials have primarily focused on low-risk (ROOBY, CORONARY), elevated-risk (GOPCABE) or high-risk patients (BBS), but not on frail patients. Therefo...

Date: 2017   |   Origin: Oasisbr

When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acu...

Silva,Pedro Gabriel Melo de Barros e; Ribeiro,Henrique Barbosa; Baruzzi,Antônio Claudio do Amaral; Silva,Expedito Eustáquio Ribeiro da

Abstract Dual antiplatelet therapy is a well-established treatment in patients with non-ST elevation acute coronary syndrome (NSTE-ACS), with class I of recommendation (level of evidence A) in current national and international guidelines. Nonetheless, these guidelines are not precise or consensual regarding the best time to start the second antiplatelet agent. The evidences are conflicting, and after more than...

Date: 2016   |   Origin: Oasisbr

Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coro...

Soeiro,Alexandre de Matos; Silva,Pedro Gabriel Melo de Barros e; Roque,Eduardo Alberto de Castro; Bossa,Aline Siqueira; César,Maria Cristina

Abstract Background: Recent studies have shown fondaparinux's superiority over enoxaparin in patients with non-ST elevation acute coronary syndrome (ACS), especially in relation to bleeding reduction. The description of this finding in a Brazilian registry has not yet been documented. Objective: To compare fondaparinux versus enoxaparin in in-hospital prognosis of non-ST elevation ACS. Methods: Multicenter retr...

Date: 2016   |   Origin: Oasisbr

Improving Indicators in a Brazilian Hospital Through Quality-Improvement Progra...

Silva,Pedro Gabriel Melo de Barros e; Baruzzi,Antônio Claudio do Amaral; Ramos,Denise Louzada; Okada,Mariana Yumi; Garcia,José Carlos Teixeira

ABSTRACT OBJECTIVE: To report the initial changes after quality-improvement programs based on STS-database in a Brazilian hospital. METHODS: Since 2011 a Brazilian hospital has joined STS-Database and in 2012 multifaceted actions based on STS reports were implemented aiming reductions in the time of mechanical ventilation and in the intensive care stay and also improvements in evidence-based perioperative thera...

Date: 2015   |   Origin: Oasisbr

Evaluation of the Society of Thoracic Surgeons score system for isolated corona...

Ikeoka,Dimas Tadahiro; Fernandes,Viviane Aparecida; Gebara,Otavio; Garcia,Jose Carlos Teixeira; Silva,Pedro Gabriel Melo de Barros e

Objective: Report the experience with the Society of Thoracic Surgeons scoring system in a Brazilian population submitted to isolated coronary artery bypass graft surgery. Methods: Data were collected from January-2010 to December-2011, and analyzed to determine the performance of the Society of Thoracic Surgeons scoring system on the determination of postoperative mortality and morbidity, using the method of t...

Date: 2014   |   Origin: Oasisbr

Implantação de protocolo institucional para o uso racional de hemoderivados e s...

Silva,Pedro Gabriel Melo de Barros e; Ikeoka,Dimas Tadahiro; Fernandes,Viviane Aparecida; Lasta,Nilza Sandra; Silva,Debora Prudencio e

OBJETIVO: Cirurgias cardíacas são, por vezes, acompanhadas de perdas sanguíneas significativas, e transfusões de sangue podem ser necessárias. No entanto, o uso indiscriminado de hemoderivados pode resultar em efeitos danosos para o paciente. Neste estudo, avaliamos os efeitos imediatos da implantação de um protocolo para o uso racional de hemoderivados no perioperatório de cirurgias de revascularização miocárd...

Date: 2013   |   Origin: Oasisbr

10 Results

Queried text

Refine Results

Author





















Date









Document Type


Access rights


Resource


Subject